{
  "units": [
    {
      "title": "Tissue cleaning and crypt isolation",
      "text": "colon tissue was first sliced open lengthwise and wiped 3–4 times with gauze (Fisher Scientific) to remove waste and mucus. The tissue was then cut into small sections of ~2” × 2” and placed into a 15 cm dish filled with PBS++ (PBS supplemented with 10 mM HEPES (Thermo Fisher Scientific), 1X GlutaMAX (Thermo Fisher Scientific), 1X Pen-Strep (Thermo Fisher Scientific), and 2.5 μg/mL Amphotericin B (Thermo Fisher Scientific). The epithelium was then minced from tissue segments using scalpels (Fisher Scientific) and collected into 50 mL conical tubes. Minced epithelium was washed 3 times with DMEM++ (Advanced DMEM/F12 (Thermo Fisher Scientific) supplemented with 10 mM HEPES, 1X GlutaMAX, 1X Pen-Strep, and 2.5 μg/mL Amphotericin B), and centrifuged at 4 °C, 500 × g for 3 min between each wash.",
      "rationale": "This is a step-by-step procedure for cleaning and preparing colon tissue for crypt isolation, with specific reagents and conditions.",
      "detected_categories": [
        {
          "id": "centrifugation",
          "hits": 1,
          "confidence": 0.333,
          "matched_patterns": [
            "centrifug"
          ]
        }
      ],
      "split_audit": {
        "char_count": 800,
        "word_count": 135,
        "sentence_count": 4,
        "category_count": 1,
        "flags": []
      }
    },
    {
      "title": "EDTA digestion for crypt release",
      "text": "After the final wash, tissue was resuspended in 25 mL of 2.5 mM EDTA in PBS and placed in an end-over-end rotator at 37 °C until crypts were visible, around 12 min.",
      "rationale": "This describes a precise, time- and temperature-controlled step to digest tissue and release crypts using EDTA.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 164,
        "word_count": 35,
        "sentence_count": 1,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Crypt filtration and centrifugation",
      "text": "Following digestion, the EDTA digestion solution was topped up with 20 mL of DMEM++, filtered through sterile gauze, and centrifuged for 3 min at 4 °C, 500 × g. The pellet was then resuspended in 10 mL PBS++, filtered through a 100 µm cell strainer, and centrifuged for 3 min at 4 °C, 500.",
      "rationale": "This outlines a clear sequence of filtration and centrifugation steps to purify crypts after digestion.",
      "detected_categories": [
        {
          "id": "centrifugation",
          "hits": 2,
          "confidence": 0.667,
          "matched_patterns": [
            "centrifug"
          ]
        }
      ],
      "split_audit": {
        "char_count": 289,
        "word_count": 53,
        "sentence_count": 2,
        "category_count": 1,
        "flags": []
      }
    },
    {
      "title": "Organoid plating in Matrigel",
      "text": "The tissue was then ready for plating in Matrigel (Corning) by resuspending in cold Matrigel and plating into 30 μL Matrigel droplets, at a density of 30–50 crypts per droplet. Once Matrigel had solidified for 30 min at 37 °C, crypts were fed with organoid growth media.",
      "rationale": "This provides exact instructions for preparing and plating organoids in Matrigel, including volume, density, and solidification time.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 270,
        "word_count": 48,
        "sentence_count": 2,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Organoid growth media composition",
      "text": "Advanced DMEM/F12 supplemented with 1X Pen-Strep, 10 mM HEPES, 1X GlutaMAX, 1X B-27 Supplement (Thermo Fisher Scientific), 0.2 nM Wnt Surrogate protein (ImmunoPrecise Antibodies), 5 nM Gastrin-1 (Tocris), 1.25mM N-Acetyl-L-Cysteine (Sigma-Aldrich), 10 mM Nicotinamide (Sigma-Aldrich), 100 µg/mL Primocin (InvivoGen), 500 nM A 83-01 (Tocris), 50 ng/mL recombinant human EGF (R&D Systems), 100 ng/mL recombinant human Noggin (R&D Systems), 250 ng/mL recombinant human R-spondin 3 (Roche), 100 ng/mL recombinant human IGF1 (BioLegend), 50 ng/mL recombinant human FGF2 (PeproTech).",
      "rationale": "This is a verbatim list of components and concentrations for organoid growth media, essential for protocol replication.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 577,
        "word_count": 98,
        "sentence_count": 1,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Media change protocol for differentiation",
      "text": "On the day after seeding, media was removed and changed to growth media without Y-27632. On day 3 after seeding, media was removed and organoids were washed twice with Advanced DMEM/F12. After washing, media was replaced with organoid media without EGF to promote differentiation.",
      "rationale": "This details a timed, stepwise media change protocol to induce organoid differentiation by removing specific factors.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 280,
        "word_count": 46,
        "sentence_count": 3,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Organoid passaging with EDTA and Trypsin",
      "text": "To passage, organoids were mechanically dislodged from Cultrex domes using a P1000 pipette tip and resuspended in cold 10 mM EDTA with 10 µM Y-27632 (STEMCELL Technologies) in a 15 mL conical tube. The tube containing organoids was then placed on an end-over-end rotator at 4 °C for 30 min and then centrifuged for 5 min at 500 ×g, 4 °C. Organoids were then resuspended in 1X Trypsin (Fisher Scientific) and placed in an end-over-end rotator for 6 min at 37 °C. Following dissociation, Trypsin was neutralized with DMEM containing 10% FBS, and organoids were centrifuged for 5 min at 500 × g, 4 °C.",
      "rationale": "This is a detailed, timed protocol for organoid dissociation and passaging using EDTA and Trypsin with specific conditions.",
      "detected_categories": [
        {
          "id": "centrifugation",
          "hits": 2,
          "confidence": 0.667,
          "matched_patterns": [
            "centrifug"
          ]
        },
        {
          "id": "cell_culture",
          "hits": 1,
          "confidence": 0.143,
          "matched_patterns": [
            "passage"
          ]
        },
        {
          "id": "dna_rna_extraction",
          "hits": 1,
          "confidence": 0.143,
          "matched_patterns": [
            "neutraliz"
          ]
        }
      ],
      "split_audit": {
        "char_count": 598,
        "word_count": 109,
        "sentence_count": 4,
        "category_count": 3,
        "flags": []
      }
    },
    {
      "title": "Microwell plate seeding protocol",
      "text": "Experiments involving microwell plates utilized 500 µm Gri3D plates (SUN bioscience). Prior to organoid seeding, storage buffer was aspirated from each well and 150 µL of Advanced DMEM/F12 was added through the pipetting port. The plate was placed in the tissue culture incubator for at least 30 min. Organoids that had been maintained in Cultrex domes for at least 5 days after passaging were removed from the ECM following the passaging protocol as above, but dissociated for 12 min in Trypsin rather than 6, or until organoids were largely single cells. Trypsin was neutralized and organoids were washed as in the passaging protocol. Following the PBS wash, organoids were resuspended in organoid growth media without Nicotinamide: Advanced DMEM/F12 supplemented with 1X Pen-Strep, 10 mM HEPES, 1X GlutaMAX, 1X B-27 Supplement, 0.2 nM Wnt Surrogate protein, 5 nM Gastrin-1, 1.25mM N-Acetyl-L-Cysteine, 100 µg/mL Primocin, 500 nM A 83-01, 50 ng/mL recombinant human EGF, 100 ng/mL recombinant human Noggin, 250 ng/mL recombinant human R-spondin 3, 100 ng/mL recombinant human IGF1, 50 ng/mL recombinant human FGF2, and with 10 µM Y-27632. Dissociated organoids were then counted using a hemocytometer and seeded into the microwell plates at a density of 200 cells per microwell, in 50 µL of media per well. The plates were placed in the incubator for 30–60 min to allow the cells to settle, after which another 100 µL of media containing 2% Matrigel was added per well. It is critical that Matrigel is added to the media while cold.",
      "rationale": "This is a comprehensive, step-by-step protocol for seeding organoids into microwell plates with precise cell density, media volumes, and Matrigel handling instructions.",
      "detected_categories": [
        {
          "id": "cell_culture",
          "hits": 5,
          "confidence": 0.714,
          "matched_patterns": [
            "incubat",
            "\\bwell\\b"
          ]
        },
        {
          "id": "dna_rna_extraction",
          "hits": 1,
          "confidence": 0.143,
          "matched_patterns": [
            "neutraliz"
          ]
        }
      ],
      "split_audit": {
        "char_count": 1534,
        "word_count": 269,
        "sentence_count": 10,
        "category_count": 2,
        "flags": []
      }
    },
    {
      "title": "DSS injury treatment protocol",
      "text": "For DSS treatment, DSS (MP Biomedicals) was dissolved in organoid media (without EGF or Nicotinamide), and added to organoid wells overnight for 16 h, after which organoids were washed twice with Advanced DMEM/F12 and then replaced with organoid media. The low and high doses considered were 0.1% DSS and 0.5% (wt/vol) DSS in media.",
      "rationale": "This specifies exact concentration, duration, and washing steps for inducing injury with DSS in organoids.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 332,
        "word_count": 58,
        "sentence_count": 2,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    },
    {
      "title": "Cytomix injury treatment protocol",
      "text": "For cytomix treatment, human recombinant TNFɑ (R&D Systems), IFNɣ (R&D systems), and IL-1β (PeproTech) were dissolved in organoid media (without EGF or Nicotinamide) for 8 hours, after which organoids were washed twice with Advanced DMEM/F12 and then replaced with organoid media. The low and high doses considered were 10 ng/mL TNFɑ, 10 ng/mL IFNɣ, 1 ng/mL IL1β and 50 ng/mL TNFɑ, 50 ng/mL IFNɣ, 5 ng/mL IL1β.",
      "rationale": "This provides exact cytokine concentrations, exposure time, and washing steps for cytomix-induced injury in organoids.",
      "detected_categories": [],
      "split_audit": {
        "char_count": 410,
        "word_count": 77,
        "sentence_count": 2,
        "category_count": 0,
        "flags": [
          "UNIT_NO_EXPERIMENT_CATEGORY"
        ]
      }
    }
  ],
  "created_at": "2026-02-16T13:00:34.972808+00:00"
}